Gong Shen
University of Washington(US)Shanghai Genon Biological Products (China)(CN)Shaoxing Second Hospital(CN)Gilead Sciences (United States)(US)Changchun University(CN)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Hepatitis C virus research, COVID-19 Clinical Research Studies, HIV Research and Treatment, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID‐19, in Healthy Subjects(2020)262 cited
- → Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: A randomized study(2014)100 cited
- → Pharmacokinetics of Emtricitabine, Tenofovir, and GS-9137 Following Coadministration of Emtricitabine/Tenofovir Disoproxil Fumarate and Ritonavir-Boosted GS-9137(2007)61 cited
- → Pharmacokinetics of Once-Daily Boosted Elvitegravir When Administered in Combination With Acid-Reducing Agents(2013)39 cited
- → Pharmacokinetics of Coadministered Ritonavir-Boosted Elvitegravir and Zidovudine, Didanosine, Stavudine, or Abacavir(2007)32 cited
- → Drug–Drug Interaction Studies Between Hepatitis C Virus Antivirals Sofosbuvir/Velpatasvir and Boosted and Unboosted Human Immunodeficiency Virus Antiretroviral Regimens in Healthy Volunteers